CellCept (Mycophenolate Mofetil Oral Suspension) and Ibritumomab Intravenous
Determining the interaction of CellCept (Mycophenolate Mofetil Oral Suspension) and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mycophenolate mofetil
Brand name: Cellcept, Myfortic, MMF
Synonyms: CellCept
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CellCept (Mycophenolate Mofetil Oral Suspension)-Ibritumomab Tiuxetan
- CellCept (Mycophenolate Mofetil Oral Suspension)-Ibrutinib
- CellCept (Mycophenolate Mofetil Oral Suspension)-Ibrutinib Capsules
- CellCept (Mycophenolate Mofetil Oral Suspension)-Ibrutinib Tablets
- CellCept (Mycophenolate Mofetil Oral Suspension)-Ibu
- CellCept (Mycophenolate Mofetil Oral Suspension)-IBU Tablets
- Ibritumomab Intravenous-CellCept (Mycophenolate Mofetil Tablets)
- Ibritumomab Intravenous-Cellcept Oral
- Ibritumomab Intravenous-Celontin
- Ibritumomab Intravenous-Celontin Kapseals
- Ibritumomab Intravenous-Cemill
- Ibritumomab Intravenous-Cemill 1000